Literature DB >> 17684762

Hereditary neuroendocrine tumors of the gastroenteropancreatic system.

Martin Anlauf1, Nele Garbrecht, Juliane Bauersfeld, Anja Schmitt, Tobias Henopp, Paul Komminoth, Philipp U Heitz, Aurel Perren, Günter Klöppel.   

Abstract

Approximately 5-10% of neuroendocrine tumors (NETs) of the gastroenteropancreatic system (GEP) have a hereditary background. The known inherited syndromes include multiple endocrine neoplasia type 1, neurofibromatosis type 1, von Hippel-Lindau disease, and the tuberous sclerosis complex. This review discusses for each of these syndromes the: (1) involved genes and specific types of mutations, (2) disease prevalence and penetrance, (3) affected neuroendocrine tissues and related clinical syndromes, (4) special morphological features of NETs and their putative precursor lesions. In addition, GEP-NETs clustering in individual families or associated with other malignancies without known genetic background are discussed.

Entities:  

Mesh:

Year:  2007        PMID: 17684762     DOI: 10.1007/s00428-007-0450-3

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  82 in total

Review 1.  Malignant endocrine tumor of the pancreas associated with von Recklinghausen's disease.

Authors:  Takashi Fujisawa; Tatsuya Osuga; Mitsuo Maeda; Norikazu Sakamoto; Tetsuo Maeda; Kazuhiko Sakaguchi; Yutaka Onishi; Masanori Toyoda; Hiroaki Maeda; Katsufumi Miyamoto; Nobuaki Kawaraya; Chosei Kusumoto; Takashi Nishigami
Journal:  J Gastroenterol       Date:  2002-01       Impact factor: 7.527

2.  Familial carcinoid tumors and subsequent cancers: a nation-wide epidemiologic study from Sweden.

Authors:  K Hemminki; X Li
Journal:  Int J Cancer       Date:  2001-11-01       Impact factor: 7.396

3.  Precursor lesions in patients with multiple endocrine neoplasia type 1-associated duodenal gastrinomas.

Authors:  Martin Anlauf; Aurel Perren; Cora Lu Meyer; Sonja Schmid; Parvin Saremaslani; Marie L Kruse; Eberhard Weihe; Paul Komminoth; Philipp U Heitz; Günter Klöppel
Journal:  Gastroenterology       Date:  2005-05       Impact factor: 22.682

Review 4.  Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways.

Authors:  David J Kwiatkowski; Brendan D Manning
Journal:  Hum Mol Genet       Date:  2005-10-15       Impact factor: 6.150

Review 5.  [Multiple endocrine neoplasia type 1 and 2. 1997 diagnostic guidelines and molecular pathology].

Authors:  P Komminoth
Journal:  Pathologe       Date:  1997-07       Impact factor: 1.011

6.  Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus.

Authors:  D Viskochil; A M Buchberg; G Xu; R M Cawthon; J Stevens; R K Wolff; M Culver; J C Carey; N G Copeland; N A Jenkins
Journal:  Cell       Date:  1990-07-13       Impact factor: 41.582

7.  Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs.

Authors:  S L Dabora; S Jozwiak; D N Franz; P S Roberts; A Nieto; J Chung; Y S Choy; M P Reeve; E Thiele; J C Egelhoff; J Kasprzyk-Obara; D Domanska-Pakiela; D J Kwiatkowski
Journal:  Am J Hum Genet       Date:  2000-12-08       Impact factor: 11.025

Review 8.  Carcinoid tumor and inflammatory bowel disease: a study of eleven cases and review of the literature.

Authors:  A J Greenstein; S Balasubramanian; N Harpaz; M Rizwan; D B Sachar
Journal:  Am J Gastroenterol       Date:  1997-04       Impact factor: 10.864

9.  Malignant pancreatic endocrine tumor in a child with tuberous sclerosis.

Authors:  Paola Francalanci; Francesca Diomedi-Camassei; Cristina Purificato; Filippo Maria Santorelli; Aldo Giannotti; Carlo Dominici; Alessandro Inserra; Renata Boldrini
Journal:  Am J Surg Pathol       Date:  2003-10       Impact factor: 6.394

Review 10.  [Somatostatin-producing endocrine pancreatic tumor in Recklinghausen's neurofibromatosis. Case report and literature review].

Authors:  P Saurenmann; R Binswanger; R Maurer; B Stamm; J Hegglin
Journal:  Schweiz Med Wochenschr       Date:  1987-07-25
View more
  26 in total

Review 1.  [Classification of gastro-entero-pancreatic neuroendocrine tumors].

Authors:  A Perren; A Schmitt; P Komminoth; M Pavel
Journal:  Radiologe       Date:  2009-03       Impact factor: 0.635

Review 2.  Nutrition and neuroendocrine tumors: An update of the literature.

Authors:  Barbara Altieri; Luigi Barrea; Roberta Modica; Giovanna Muscogiuri; Silvia Savastano; Annamaria Colao; Antongiulio Faggiano
Journal:  Rev Endocr Metab Disord       Date:  2018-06       Impact factor: 6.514

Review 3.  Hormone secreting gastro-entero-pancreatic neuroendocrine neoplasias (GEP-NEN): When to consider, how to diagnose?

Authors:  Christian Fottner; Martina Ferrata; Matthias M Weber
Journal:  Rev Endocr Metab Disord       Date:  2017-12       Impact factor: 6.514

4.  Genetic associations with sporadic neuroendocrine tumor risk.

Authors:  Monica Ter-Minassian; Zhaoxi Wang; Kofi Asomaning; Michael C Wu; Chen-Yu Liu; Jessica K Paulus; Geoffrey Liu; Penelope A Bradbury; Rihong Zhai; Li Su; Christine S Frauenhoffer; Susanne M Hooshmand; Immaculata De Vivo; Xihong Lin; David C Christiani; Matthew H Kulke
Journal:  Carcinogenesis       Date:  2011-05-23       Impact factor: 4.944

Review 5.  Endocrine tumours in neurofibromatosis type 1, tuberous sclerosis and related syndromes.

Authors:  Maya B Lodish; Constantine A Stratakis
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2010-06       Impact factor: 4.690

6.  Imaging features of malignant abdominal neuroendocrine tumors with rare presentation.

Authors:  Giuseppe Corrias; Serena Monti; Natally Horvat; Laura Tang; Olca Basturk; Luca Saba; Lorenzo Mannelli
Journal:  Clin Imaging       Date:  2018-02-08       Impact factor: 1.605

7.  Secondary malignancy in patients with sporadic neuroendocrine neoplasia.

Authors:  M Krausch; A Raffel; M Anlauf; M Schott; N Lehwald; A Krieg; F Kröpil; K Cupisti; W T Knoefel
Journal:  Endocrine       Date:  2013-03-14       Impact factor: 3.633

8.  Syndromic versus non-syndromic sporadic gastrin-producing neuroendocrine tumors of the duodenum: comparison of pathological features and biological behavior.

Authors:  M Johannes Rosentraeger; Nele Garbrecht; Martin Anlauf; Andreas Raffel; Wolfram T Knoefel; Bertram Wiedenmann; Günter Klöppel
Journal:  Virchows Arch       Date:  2015-12-09       Impact factor: 4.064

Review 9.  Gastroenteropancreatic neuroendocrine tumors: indications for and pitfalls of frozen section examination.

Authors:  Anne Couvelard; Alain Sauvanet
Journal:  Virchows Arch       Date:  2008-10-07       Impact factor: 4.064

Review 10.  Site-specific biology and pathology of gastroenteropancreatic neuroendocrine tumors.

Authors:  Günter Klöppel; Guido Rindi; Martin Anlauf; Aurel Perren; Paul Komminoth
Journal:  Virchows Arch       Date:  2007-08-08       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.